Société Milestone Pharmaceuticals Inc.
Actions
MIST
CA59935V1076
Recherche biotechnologique et médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
1,69 USD | +3,05% | +9,74% | +1,20% |
Métier
Nombre d'employés: 47
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Cardiovascular Medicines
100,0
%
| 5 | 100,0 % | 1 | 100,0 % | -80,00% |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Canada
100,0
%
| 5 | 100,0 % | 1 | 100,0 % | -80,00% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Joseph Oliveto
CEO | Chief Executive Officer | 56 | 07/03/17 |
Amit Hasija
DFI | Director of Finance/CFO | 51 | 09/09/19 |
Anita Holz
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/22 |
Chief Tech/Sci/R&D Officer | - | 01/11/21 | |
David Bharucha
CTO | Chief Tech/Sci/R&D Officer | 62 | 15/02/22 |
Jeff Nelson
COO | Chief Operating Officer | 42 | 01/06/20 |
Kimberly Sheehan
HRO | Human Resources Officer | - | 01/04/22 |
Roshan Girglani
SAM | Sales & Marketing | - | 01/08/22 |
Lorenz Muller
PRN | Corporate Officer/Principal | 60 | 01/10/17 |
Guy Rousseau
LAW | General Counsel | - | 01/01/16 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Seth Fischer
BRD | Director/Board Member | 68 | 21/03/23 |
Joseph Oliveto
CEO | Chief Executive Officer | 56 | 07/03/17 |
Debra Liebert
BRD | Director/Board Member | 67 | 01/06/15 |
Director/Board Member | 75 | 11/11/19 | |
Michael Tomsicek
BRD | Director/Board Member | 58 | 01/04/19 |
Lisa Giles
BRD | Director/Board Member | 65 | 01/10/20 |
Robert Wills
CHM | Chairman | 70 | 01/10/20 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 53 149 778 | 52 815 928 ( 99,37 %) | 0 | 99,37 % |
Coordonnées société
Milestone Pharmaceuticals, Inc.
1111 Dr. Frederik-Philips Boulevard Suite 420
H4M 2X6, Montréal
+
http://www.milestonepharma.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+1,20% | 106 M | |
+8,96% | 105 Md | |
-1,43% | 104 Md | |
+4,40% | 22,94 Md | |
-12,15% | 22,34 Md | |
-4,36% | 19,25 Md | |
-39,98% | 17,08 Md | |
-10,04% | 16,96 Md | |
+6,79% | 14,16 Md | |
+38,61% | 12,63 Md |
- Bourse
- Actions
- Action MIST
- Société Milestone Pharmaceuticals Inc.